Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe
-
Upload
pharma-intelligence -
Category
Health & Medicine
-
view
103 -
download
1
Transcript of Brexit: Issues And Opportunities As UK Life Sciences Define A New Relationship In Europe
Brexit: Issues and opportunities as UK life sciences define a new relationship in Europe
Webinar sponsored by
Participants:• Steve Bates, Chief Executive Officer,
BIA
• Virginia Acha, Executive Director, ABPI
• Jo Pisani, Partner, PwC
• Lindsey Barras, Director, PwC
• Harren Jhoti, President and CEO, Astex Pharmaceuticals
• Ian Schofield, Principal Analyst, Scrip
• Sukaina Virji, News Editor, Scrip (Chair)
Steve Bates, Chief Executive Officer, BIA
Virginia Acha, Executive Director, ABPI
Jo Pisani, Partner, PwC
Lindsey BarrasDirectorPwC
Harren JhotiPresident and CEOAstex Pharmaceuticals
Ian SchofieldPrincipal AnalystScrip
Sukaina VirjiNews EditorScrip (Chair)
Brexit: What do we actually know?
What are the key concerns around regulation, people, trade and innovation?
What should be the key elements of the government’s Brexit strategy?
What opportunities does Brexit throw out for UK life sciences?
What happens next on Brexit?
Thank you very much for joining us today. If you have any further questions or comments, please email them to [email protected]
Webinar sponsored by